AKT1 and pachyonychia congenita: To further determine the mechanism of NGF/TrkA for the proliferation and invasion of PC, we evaluated PI3K signalling and its downstream targets, AKT and GSK, treated with si‐TrkA and LY294002 (an inhibitor of PI3K) (Figure 6).